Experiment 989502
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Camptotheca acuminata (NYSSACEAE) |
| Citation | MUGGIA,FM: CREAVEN,PJ: HANSEN,HH: COHEN,MH: SELAWRY,OS:. (1972). PHASE I CLINICAL TRIAL OF WEEKLY AND DAILY TREATMENT WITH CAMPTOTHECIN (NSC-100880): CORRELATION WITH PRECLINICAL STUDIES.. 56() |
| Amount utilized | |
| Compound isolated | |
| Disease | PHASE I CLINICAL TRIAL IN 15 CANCER PATIENTS EVALUATED FOR TOLERANCE TO WEEKLY AND DAILY TREATMENT LEUKOPENIA AND THROMBOCYTOPENIA WERE THE MOST FREQUENT SIDE EFFECTS.BLADDER TOXICITY WAS DOSE LIMITING IN 3 PATIENTS CONTINUED STUDY IN OTHER SUBJECTS WAS RECOMMENDED |
| Dose amount | 20.0 MG |
| Number | 1 |
| Qualitative result | EQUIVOCAL |
| Animal | HUMAN ADULT |
| Per unit | SQ M BODY SURFACE |
| Dose expression | DOSE |
| Gender | GIVEN TO BOTH SEXES |